The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Contract Research And Manufacturing Services (CRAMS) Market Projected To Become By 2030 Based On Its 2026 Valuation?
The market size for contract research and manufacturing services (crams) has experienced rapid expansion in recent years. It is projected to grow from $155.61 billion in 2025 to $171.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.4%. This historic growth can be attributed to various factors, including escalating r&d costs in the pharmaceutical sector, a growing demand for innovative drugs, insufficient in-house manufacturing capabilities, increasing regulatory complexities, and the emergence of biotechnology companies.
The contract research and manufacturing services (crams) market is poised for significant expansion in the coming years. Projections indicate it will reach $258.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth is driven by factors such as the increasing embrace of biologics and cutting-edge therapies, expanded outsourcing of clinical trials, the rising need for personalized medicine, innovations in manufacturing automation technology, and an uptick in contract manufacturing for medical devices. Key trends anticipated during this period encompass the outsourcing of pharmaceutical research and development, an increase in biologics manufacturing services, heightened demand for analytical testing and quality control, expansion in custom synthesis and production services, and the growing practice of contract manufacturing for medical devices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6041&type=smp
What Drivers Are Shaping The Future Growth Of The Contract Research And Manufacturing Services (CRAMS) Market?
An expanding elderly demographic facing diverse chronic illnesses is anticipated to favorably influence the contract research and manufacturing services (CRAMS) market’s expansion over the forecast period. The global elderly population is undergoing rapid growth, a trend projected to persist throughout the forecast period. This surge in the geriatric population will consequently lead to a higher incidence of conditions like cancer, diabetes, Alzheimer’s, arthritis, and other ailments, thereby boosting the need for various drugs or medicines. Consequently, the demand for contract research and manufacturing services will experience growth. As an illustration, the Australian Bureau of Statistics, a statistical body based in Australia, reported in September 2023 that Australia’s population, recorded as 26 million in 2022, is projected to expand to a range of 34.3 million to 45.9 million by 2071. Furthermore, the current median age of 38.5 years is expected to increase to between 43.8 and 47.6 years. Thus, the expanding ageing population serves as a key impetus for the growth of the contract research and manufacturing services (CRAMS) market.
What Segment Groups Are Identified Within The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (crams) market covered in this report is segmented –
1) By Services: Manufacturing, Research
2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes
3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging
Subsegments:
1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production
2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services
What Trends Are Advancing Progress In The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (CRAMS) market is increasingly adopting Artificial Intelligence (AI) to solidify its market standing. AI, a segment of computer science, focuses on replicating human behavior in machines. It can contribute to preventing expensive maintenance through predictive scheduling and providing support to the healthcare system. As an illustration, in June 2024, Medidata, a US-based technology firm, released the Medidata clinical data studio. This studio aims to integrate and manage clinical trial data from various sources to enhance the efficiency and accuracy of clinical research. It employs artificial intelligence to simplify data review and reconciliation, thereby enabling study teams to more effectively identify potential data anomalies and safety signals. The platform provides a complete workspace for data integration, transformation, and management, allowing users to implement robust risk-based quality management strategies and access real-time information.
Which Companies Hold Significant Positions In The Contract Research And Manufacturing Services (CRAMS) Market?
Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG
Read the full contract research and manufacturing services (crams) market report here:
Which Geographic Regions Are Influencing Demand In The Contract Research And Manufacturing Services (CRAMS) Market?
North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in the contract research and manufacturing services (crams) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Contract Research And Manufacturing Services (CRAMS) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6041&type=smp
Browse Through More Reports Similar to the Global Contract Research And Manufacturing Services (CRAMS) Market 2026, By The Business Research Company
Contract Research And Manufacturing Services Market Report 2026
Contract Development Manufacturing Organizations Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model